Bacchus Barua

National pharmacare likely won’t help Canadians who need it the most

• Instead of introducing a new national program as a blunt instrument, the Trudeau government could specifically target the Canadians who struggle to pay for

Opinion | BY BACCHUS BARUA, JAKE FUSS | September 20, 2023

National pharmacare likely won’t help Canadians who need it the most

Opinion | BY BACCHUS BARUA, JAKE FUSS | September 20, 2023

• Instead of introducing a new national program as a blunt instrument, the Trudeau government could specifically target the Canadians who struggle to pay for

National pharmacare likely won’t help Canadians who need it the most

Opinion | BY BACCHUS BARUA, JAKE FUSS | September 20, 2023

• Instead of introducing a new national program as a blunt instrument, the Trudeau government could specifically target the Canadians who struggle to pay for

Health minister’s claims about Ottawa’s pharmacare plan deserve a second look

• With the release of Dr. Eric Hoskins’ report on June 12, national pharmacare will likely be a central issue in this fall’s federal election.

Opinion | BY BACCHUS BARUA, JASON CLEMENS | July 3, 2019

Health minister’s claims about Ottawa’s pharmacare plan deserve a second look

Opinion | BY BACCHUS BARUA, JASON CLEMENS | July 3, 2019

• With the release of Dr. Eric Hoskins’ report on June 12, national pharmacare will likely be a central issue in this fall’s federal election.

Health minister’s claims about Ottawa’s pharmacare plan deserve a second look

Opinion | BY BACCHUS BARUA, JASON CLEMENS | July 3, 2019

• With the release of Dr. Eric Hoskins’ report on June 12, national pharmacare will likely be a central issue in this fall’s federal election.

More Stories